COVID-19 Rapid Antigen Lateral Flow Test Kits
PRICE BREAKS - The more you buy, the more you save
Express COVID-19 test results within 15 minutes.
The proprietary sourced Covid-19 Lateral flow test is an immunochromatographic test for the qualitative detection of the spike protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens from individuals who are suspected of COVID-19.
- Accessible and portable tool for Point-Of-Care (POC) testing
- No analyser required for reading results
- Results within 15 MINUTES
Email us at email@example.com if you'd like more information or to discuss bulk pricing.
It is ideal for use in a variety of scenarios, such as to:
- Determine the need for further testing/treatment in a clinical/pharmacy setting and private long-term care facilities
- Verify if patients are ready for release from quarantine
- Screening individuals entering:
- Manufacturing plants
- Private Venues
- Corporate Offices
- Educational campuses and schools
- Travel industry: Cruise ships, airports
- Pubs, Bars, and Restaurants
- Recreational spaces
Sensitivity: 84.6% (94% within first 8 days of onset of symptoms)
Specificity: 90.0% (94% within 8 days of onset of symptoms)
Storage: Test kit can be stored at 2-30ºC (35-86ºF). DO NOT FREEZE
Clinical Study Population: Clinical performance characteristics of the COVID-19 antigen test was evaluated in a protective study, at two different sites, where 99 patients were enrolled into the study and tested. Patients were a mix of symptomatic patients suspected of COVID-19 (59) and asymptomatic (40) patients.
Intended Use: COVID-19 Lateral Flow Assay is an immunochromatographic assay for the qualitative detection of the spike protein antigen from SARS-CoV-2 in nasopharyngeal (NP)swab specimens from individuals who are suspected of COVID-19 by their healthcare
provider. The assay is intended for professional and laboratory use.
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. A positive result does not rule out co-infections with other pathogens. The agent detected may not be the definite cause of disease. The COVID-19 Lateral Flow Assay does not differentiate between SARS-CoV and SARS-CoV-2.
Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results do not rule out COVID-19 and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. The COVID-19 Lateral Flow Assay is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings.
- COVID-19 Lateral Flow Assay
- Test Cartridge
- 1.5ml Microfuge Tube
- Dual Bulb Fixed Volume Pastette (100μL)
- COVID-19 Reagent Solution Dropper Bottle (White Cap) 2 x 15ml
- Instructions for use
- Procedure Card
- Nasopharyngeal Swabs
Certificates, clinical trial information, and procedure cards available upon request.